These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3887531)

  • 1. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
    Szekeres L; Krassói I; Pataricza J; Udvary E
    Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action.
    Szekeres L; Koltai M; Pataricza J; Takáts I; Udvary E
    Biomed Biochim Acta; 1984; 43(8-9):S135-42. PubMed ID: 6393960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of epinephrine-exacerbated coronary thrombus formation by prostacyclin in the dog.
    Bertha BG; Folts JD
    J Lab Clin Med; 1984 Feb; 103(2):204-14. PubMed ID: 6363581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
    Fletcher JR; Ramwell PW
    Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S; Sotomora R; Rao GH; Gerrard JM; Foker JE; White JG
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-oxo-PGI2 induced late protective action from arrhythmias due to local myocardial ischemia.
    Udvary E; Végh A; Szekeres L
    Bratisl Lek Listy; 1991; 92(3-4):146-9. PubMed ID: 2029655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.
    Jouve R; Puddu PE; Langlet F; Guillen JC; Gautier T; Cano JP; Serradimigni A
    J Pharmacol; 1985; 16(2):139-57. PubMed ID: 3903352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
    Fiedler VB; Mardin M
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
    Takahashi T; Takahashi K; Kishi-Tanikawa S; Tsuchida K; Araki H; Higuchi S
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1028-33. PubMed ID: 8819482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the nature and molecular basis of prostacyclin induced late cardiac changes.
    Szekeres L; Németh M; Szilvássy Z; Tósaki A; Udvary E; Végh E
    Biomed Biochim Acta; 1988; 47(10-11):S6-11. PubMed ID: 3073771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of antiplatelet effects from myocardial cytoprotective activity during acute myocardial ischemia in cats by a new carbacyclin derivative (ZK 36 375).
    Schrör K; Darius H; Ohlendorf R; Matzky R; Klaus W
    J Cardiovasc Pharmacol; 1982; 4(4):554-61. PubMed ID: 6181328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-oxo-PGI2 induced late appearing and long lasting antiischaemic and antiarrhythmic action in dogs.
    Végh A; Udvary E; Szekeres L; Szilvássy Z
    Biomed Biochim Acta; 1988; 47(10-11):S31-4. PubMed ID: 3073767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG; Winniford MD; Campbell WB; Hillis LD
    Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
    Takeda H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin for acute coronary insufficiency.
    Szczeklik A; Szczeklik J; Nizankowski R; Głuszko P
    Artery; 1980; 8(1):7-11. PubMed ID: 6775619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.